Puli Hoxhaj

Pellumbeshe Hoxhaj serves as a Contract Specialist responsible for managing the acquisition lifecycle for complex scientific and pharmaceutical products, ensuring compliance with federal procurement regulations and agency mission objectives. Specializing in competitive solicitation, contract negotiation, and post-award administration, Hoxhaj plays a critical role in securing mission-critical goods that support research, diagnostic, and manufacturing capabilities. Their acquisitions typically involve high-compliance, technical products requiring detailed specifications, performance standards, and regulatory alignment, particularly in life sciences and analytical instrumentation domains. Hoxhaj engages with a diverse pool of vendors, including large manufacturers and specialized small businesses, to procure advanced pharmaceutical preparations, in-vitro diagnostic substances, and laboratory instrumentation. While no single contractor dominates their portfolio, the contracting pattern reflects a preference for established suppliers with proven technical capabilities and quality assurance systems compliant with FDA and ISO standards. Vendor relationships are built on performance transparency, technical responsiveness, and adherence to contract deliverables, with a focus on sustaining supply chain reliability for sensitive scientific applications. Hoxhaj’s set-aside profile reflects a strong orientation toward open competition, with 95.6% of acquisitions conducted without socioeconomic set-asides. However, a consistent 4.4% of awards are reserved under Total Small Business Set-Asides (FAR 19.5), demonstrating a measured but intentional commitment to small business participation. While no 8(a), HUBZone, or SDVOSB set-asides are currently evident, the reliance on small business general contractors suggests an underlying preference for competitive small business engagement within the broader small business category. The primary procurement focus centers on NAICS 325412 (Pharmaceutical Preparation Manufacturing), with significant activity in analytical laboratory instruments (334516), research and development in life sciences (541715), in-vitro diagnostic substances (325413), and biological product manufacturing (325414). Hoxhaj’s expertise lies in procuring highly regulated, science-driven products requiring technical validation, sterile manufacturing controls, and compliance with Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP).